ÃèÊö£ºUbiquigent ´úÀí£¬Ubiquigent ÉϺ£´úÀí£¬Ubiquigent ±±¾©´úÀí£¬ Ubiquigent ×Ü´úÀí, Ubiquigent Ò»¼¶´úÀí£¬ Ubiquigent ÌØÔ¼´úÀíÉϺ£¿·¢¡¤K8ʵÑéÊÔ¼ÁÓÐÏÞ¹«Ë¾ Ubiquigent רҵ´úÀí£¬¾ßÌå²úÆ·ÐÅÏ¢»¶Óµçѯ£º4006551678
ÊÀ½ç*ʵÑé²ÄÁϹ©Ó¦ÉÌ Ubiquigent ÕýʽÊÚȨÉϺ£¿·¢¡¤K8ΪÆäÖйú´úÀí£¬ Ubiquigent ÔÚÒ»Ö±ÊÇÐÐÒµµÄ*,һֱΪ¹ã´ó¿ÆÑпͻ§ÌṩzuiΪÓÅÖʵIJúÆ·ºÍ·þÎñ,ÉϺ£¿·¢¡¤K8Ò»Ö±±ü³ÐΪÖйú¿ÆÑпͻ§´øÀ´µÄ²úÆ·£¬µÄ·þÎñ£¬Ç©Ô¼ Ubiquigent ¾ÍÊÇΪÁ˸ø¹ã´ó¿ÆÑпͻ§´øÀ´¸ü¼ÓÍêÉÆµÄ²úÆ·ºÍ·þÎñ,ÄúµÄÂúÒ⽫ÊÇ¿·¢¡¤K8zui´óµÄÊÕ»ñ
Ubiquigent Öйú´úÀí, Ubiquigent ÉϺ£´úÀí£¬ Ubiquigent ±±¾©´úÀí£¬Ubiquigent ¹ã¶«´úÀí£¬ Ubiquigent ½ËÕ´úÀíUbiquigent ºþ±±´úÀí,Ubiquigent Ìì½ò,Ubiquigent ºÚÁú½´úÀí,Ubiquigent ÄÚÃɹŴúÀí,Ubiquigent ¼ªÁÖ´úÀí,Ubiquigent ¸£½¨´úÀí, Ubiquigent ½ËÕ´úÀí, Ubiquigent Õã½´úÀí, Ubiquigent ËÄ´¨´úÀí,
Ubiquigent LimitedÊÇÒ©Îï·¢ÏÖ·þÎñµÄרҵ¿ª·¢É̺͹©Ó¦ÉÌ£¬ÎªÉúÃü¿ÆÑ§Ñо¿½çÌṩ¸ßÖÊÁ¿µÄÑо¿¹¤¾ßºÍ»¯Ñ§¡£
*µÄ¿ÆÑ§ºÍÉÌÒµÀûÒæÓÐÃ÷È·µÄÖØµã; ¼´·ºËØ£¬·ºËØÑùºÍ×ÛºÏÐźÅϵͳ¡£
¹«Ë¾ÒѾÓë¿ÆÑ§Ñо¿ÈËÔ±½øÐпÆÑ§ºÍÉÌÒµÈÏÖ¤£¬´ÓÊ»ù´¡¿ÆÑ§·¢ÏÖ£¬ÖÆÒ©ºÍÉúÎï¿Æ¼¼¹«Ë¾µÄ¿ÆÑ§¼ÒÃÇ̽Ë÷ÁË·ºËؼ¶ÁªÖصãÒ©Îï·¢ÏÖµÄDZÁ¦¡£
*µÄÓÅÊÆµÃÒæÓÚÃÀ¹ú˽ÈËͶ×ÊÕߣ¬Ó¢¹úҽѧÑо¿ÀíÊ»áºÍµËµÏ´óѧµÈ¸ßËØÖʵÄÖ§³Ö¡£¸Ã¹«Ë¾µÄ×ܲ¿ºÍʵÑéÊÒÒµÎñÉèÔÚÓ¢¹ú£¬Î»ÓÚÅþÁڵ˵ϴóѧMRCµ°°×Á×ËữºÍ·ºËØ»¯µ¥Î»µÄÒ»¸öÁ¼ºÃµÄÉèÊ©£¨ÓÉPhilip Cohen½ÌÊÚ´´Á¢£©¡£³ýÁËUbiquigent×Ô¼ºµÄÉèÊ©ºÍ¹¦ÄÜÖ®Í⣬ÕâÖÖ½Ó½ü¿ÉÒÔËæÊ±»ñµÃ´óÁ¿¶îÍâµÄ¿ÆÑ§×¨ÒµÖªÊ¶£¨1,000¶àÃûÉúÃü¿ÆÑ§Ñо¿ÈËÔ±£©£¬¼¼ÊõÄÜÁ¦ÒÔ¼°²â¶¨ºÍ·ÖÎöƽ̨¡£
UbiquigentÌṩÀ´×Ô·ºËص°°×øÌ壨UPS£©Í¾¾¶µÄ¿¹È«³¤»ò²¿·Öµ°°×ÖʵĿ¹Ìå; ÕâЩ°üÀ¨E2׺ºÏø£¬E3Á¬½Óø£¬DUB£¬·ºËؽáºÏµ°°×µ×ÎïºÍ׺ºÏÎÌå¡£¿¹¶à¾Û·ºËØ»¯Å¼ÁªÎïmAb£¨FK1£©ºÍ¿¹µ¥ºÍ¶à·ºËØ»¯Å¼ÁªÎïmAb£¨FK2£©Òѱ»¹ã·º±íÕ÷£¬¿ÉÓÃÓÚ·Ö±ð֤ʵ¶à·ºËØ»¯ºÍµ¥·ºµ°°×¶à¾Û·ºËØ»¯µ°°×żÁªÎïµÄÌØÒìÐÔʶ±ð£¬µ«²»ÏÔʾÓëÓÎÀëµÄ·´Ó¦ÐÔ·ºËØ¡£Ubiquigent»¹ÌṩÁËÐí¶à¼¤Ã¸¿¹Ì壬Ïñ·ºËØ»¯Ò»Ñù£¬Á×ËữÊÇÒ»ÖÖ¿ÉÄæµÄ·ÒëºóÐÞÊΡ£Òì³£µ°°×Á×ËữÊǼ²²¡µÄÔÒò»òºó¹û£¬°üÀ¨°©Ö¢£¬ÌÇÄò²¡ºÍÑ×ÐÔ¼²²¡£¬¶ø±àÂëµ°°×¼¤Ã¸ºÍÁ×ËáøµÄ»ùÒòÖеÄȱÏÝÊÇÐí¶àÒÅ´«ÐÔ¼²²¡µÄ»ù´¡¡£Ô¼500¸öµ°°×¼¤Ã¸±àÂëÔÚÈËÀà»ùÒò×éÖУ¬ËüÃÇռĿǰÓÉÒ©Îï·¢ÏÖ¹«Ë¾×·ÇóµÄ·Ö×ӰбêµÄÔ¼25£¥¡£ÕâÁ½¸ö¹Ø¼üµÄϸ°ûÄÚϵͳ֮¼ä´æÔÚ×ÅÃ÷ÏԵĴ®ÈÅ£¬Á×ËữºÍ·ºËØ»¯¡£
²¿·Ö²úÆ·ÐÅÏ¢ÈçÏ£º
¿·¢¡¤K8¹«Ë¾zui´óÓÅÊÆÊÇÇ¿´óµÄ²É¹º£¬
1£º»ù±¾Ê²Ã´¶¼Äܽø¿Ú£¬ÑªÇ壬¿¹Ì壬ºÄ²Ä£¬»¹Óв¿·ÖÏÞÖÆ½ø¿ÚµÄ£¬
2£º»õÆ·È«£¬ÏÖ¾Óª¹ý700¶à¸öÆ·ÅÆ£¬»ù±¾ËùÓÐÉúÎïÊÔ¼ÁºÄ²Ä¶¼¿ÉÒÔ½ø¿Ú£¬ÌرðÊÇÀ䯫µÄ²úÆ·ÄǾ͸üÓÐÓÅÊÆ£¬
3£ºÌṩ¼Ó¼±·þÎñ£¬Ò»°ã1-2Öܵ½»õ£¬³¬¹ýʱÏÞ¼Ó¼±·ÑÈ«Ãâ
4£º¼Û¸ñ¹«µÀ£¬¾ø´ó²¿·Ö¼Û¸ñÓÐÓÅÊÆ£¬µ±È»²»Äܱ£Ö¤100%²úÆ·¶¼ÊÇ,ÒòΪÒâζ×ÅûÓзþÎñ.
5£ºÁ¼ºÃµÄÐÅÓþ£¬´ó²¿·Ö¿Í»§¿·¢¡¤K8Ìṩ»õµ½¸¶¿î·þÎñ£¬¿Í»§°üÀ¨Ç廪£¬±±´ó ½»´ó ¸´µ©£¬ÖÐɽµÈ100¶àËù´óѧ£¬ROCHE£¬°¢Ë¹Àû¿µ£¬¹úÒ© £¬fisherµÈ500¶à¼Ò¹«Ë¾
6£º¿·¢¡¤K8»¹ÊÇSanta,Advanced Biotechnologies Inc, Ubiquigent ,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. Dako,Inc, GePromegaridege,Ubiquigent Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,Ubiquigent , Polysciences,prospecbi, QA-BIO,quickzyme,FULLERLABS,INC,sterlitech£»sysy,TriLink BioTechnologies,Inc£»worthington-biochem,zyagenµÈ¼¸Ê®¼Ò¹úÍ⹫˾ÊÚȨ´úÀí¡£
7£º¿·¢¡¤K8»¹ÊÇinvitrogen,qiagen,Midland BioProducts Corporationam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegendµÈÖªÃû*Åú·¢£¬»¶ÓºÏ×÷¡£
ÉϺ£¿·¢¡¤K8ʵÑéÊÔ¼ÁÓÐÏÞ¹«Ë¾
£º
°ì¹«£º
:
µØÖ·£ºÉϺ£ÊÐÆÖ¶«ÐÂÇø³¿Ñô·225Ū¶«·½ÏÖ´úÉÌÒµ¹ã³¡46ºÅ303ÊÒ(½ü¶«Í¤Â·)